Genovis AB (publ.) (STO:GENO)
24.00
+1.05 (4.58%)
Aug 22, 2025, 5:29 PM CET
Genovis AB (publ.) Market Cap
Genovis AB (publ.) has a market cap or net worth of 1.59 billion as of August 22, 2025. Its market cap has decreased by -15.61% in one year.
Market Cap
1.59B
Enterprise Value
1.50B
Revenue
123.19M
Ranking
n/a
PE Ratio
58.28
Stock Price
24.00
Market Cap Chart
Since April 18, 2008, Genovis AB (publ.)'s market cap has increased from 7.51M to 1.59B, an increase of 21,002.02%. That is a compound annual growth rate of 36.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 1.59B | -1.95% |
Dec 30, 2024 | 1.62B | -52.50% |
Dec 29, 2023 | 3.40B | 13.17% |
Dec 30, 2022 | 3.01B | -37.05% |
Dec 30, 2021 | 4.78B | 131.75% |
Dec 30, 2020 | 2.06B | 30.72% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 97.94B |
Sectra AB | 68.25B |
Getinge AB | 56.43B |
Camurus AB | 41.09B |
Medicover AB | 40.92B |
Asker Healthcare Group AB | 37.36B |
BioArctic AB | 21.14B |
AddLife AB | 20.92B |